Multiple Myeloma in Relapse Recruiting Phase 2 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0036092 (Multiple Myeloma in Relapse)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03601624Pomalidomide/Cyclophosphamide/Dexamethasone in Relapse Refractory Myeloma: Safety Profile in MexicansTreatment